NextCure Statistics
Total Valuation
NextCure has a market cap or net worth of $27.17 million. The enterprise value is -$42.02 million.
Important Dates
The last earnings date was Thursday, November 7, 2024, after market close.
| Earnings Date | Nov 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NextCure has 28.01 million shares outstanding. The number of shares has increased by 0.48% in one year.
| Current Share Class | 28.01M |
| Shares Outstanding | 28.01M |
| Shares Change (YoY) | +0.48% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 1.81% |
| Owned by Institutions (%) | 30.21% |
| Float | 18.06M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.36 |
| P/TBV Ratio | 0.36 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.07, with a Debt / Equity ratio of 0.08.
| Current Ratio | 9.07 |
| Quick Ratio | 8.72 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -57.93% and return on invested capital (ROIC) is -35.21%.
| Return on Equity (ROE) | -57.93% |
| Return on Assets (ROA) | -32.86% |
| Return on Capital (ROIC) | -35.21% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$713,634 |
| Employee Count | 82 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -17.45% in the last 52 weeks. The beta is 0.61, so NextCure's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -17.45% |
| 50-Day Moving Average | 1.25 |
| 200-Day Moving Average | 1.49 |
| Relative Strength Index (RSI) | 34.08 |
| Average Volume (20 Days) | 222,924 |
Short Selling Information
The latest short interest is 50,437, so 0.18% of the outstanding shares have been sold short.
| Short Interest | 50,437 |
| Short Previous Month | 44,860 |
| Short % of Shares Out | 0.18% |
| Short % of Float | 0.28% |
| Short Ratio (days to cover) | 1.89 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -60.54M |
| Pretax Income | -61.28M |
| Net Income | -58.52M |
| EBITDA | -57.53M |
| EBIT | -60.54M |
| Earnings Per Share (EPS) | -$2.09 |
Full Income StatementBalance Sheet
The company has $75.31 million in cash and $6.12 million in debt, giving a net cash position of $69.19 million or $2.47 per share.
| Cash & Cash Equivalents | 75.31M |
| Total Debt | 6.12M |
| Net Cash | 69.19M |
| Net Cash Per Share | $2.47 |
| Equity (Book Value) | 75.59M |
| Book Value Per Share | 2.70 |
| Working Capital | 70.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$44.51 million and capital expenditures -$521,000, giving a free cash flow of -$45.03 million.
| Operating Cash Flow | -44.51M |
| Capital Expenditures | -521,000 |
| Free Cash Flow | -45.03M |
| FCF Per Share | -$1.61 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |